El-Sabrout R A, Reul G J
Department of Cardiovascular Surgery, Texas Heart Institute at St Luke's Episcopal Hospital, Houston 77030, USA.
Tex Heart Inst J. 2001;28(4):254-64.
Suprarenal or supraceliac aortic clamping during repair of infrarenal abdominal aortic aneurysms can be complicated by renal, hepatic, and intestinal ischemia. To determine whether suprarenal or supraceliac clamping increases morbidity and mortality we retrospectively reviewed our recent nonrandomized experience. Between January 1993 and December 1998, 716 patients underwent elective (n=682) or urgent (n=34) infrarenal abdominal aortic aneurysm repair. Infrarenal clamping was used in 516 (72. 1 %) and suprarenal or supraceliac clamping in 200 (279%). The suprarenal/supraceliac group had significantly more older patients (> or = 70 years of age) (65.5% vs 477%) and a higher incidence of preoperative renal insufficiency (75% vs 5.5%). Suprarenal or supraceliac clamping was used during repair of ruptured (n=25), juxtarenal (n=7), or inflammatory abdominal aortic aneurysms (n=4); during concomitant renal or visceral revascularization (n=43); in other difficult settings (n=13); or at the surgeon's discretion (n=108). The decision for such clamping was always made during surgery In treating ruptured aneurysms, suprarenal/supraceliac clamping (25/200) was used more often than infrarenal clamping (9/516) (12.5% vs 1.74%). Operative times were similar in both groups, but transfusion requirements and length of hospital stay were slightly greater in the suprarenal/supraceliac group. Perioperative mortality was 3.1% overall, but higher in the suprarenal/ supraceliac group than in the infrarenal (75% vs 1.4%). Postoperative complications developed in 26 (13%) of patients who underwent suprarenal/supraceliac clamping. Abdominal re-exploration was required in 9 other patients. We conclude that, despite associated comorbidities, elective suprarenal/supraceliac clamping during infrarenal abdominal aortic aneurysm repair is safe, facilitates repair, and does not significantly increase mortality.
在肾下腹主动脉瘤修复过程中,肾上或腹腔动脉上主动脉钳夹可能会并发肾、肝和肠道缺血。为了确定肾上或腹腔动脉上钳夹是否会增加发病率和死亡率,我们回顾性地分析了我们最近的非随机经验。在1993年1月至1998年12月期间,716例患者接受了择期(n = 682)或急诊(n = 34)肾下腹主动脉瘤修复术。516例(72.1%)采用肾下钳夹,200例(27.9%)采用肾上或腹腔动脉上钳夹。肾上/腹腔动脉上组老年患者(≥70岁)明显更多(65.5%对47.7%),术前肾功能不全的发生率更高(7.5%对5.5%)。在破裂性(n = 25)、肾旁性(n = 7)或炎性腹主动脉瘤(n = 4)修复过程中;在同时进行肾或内脏血管重建时(n = 43);在其他困难情况下(n = 13);或根据外科医生的判断(n = 108)采用肾上或腹腔动脉上钳夹。这种钳夹的决定总是在手术期间做出。在治疗破裂性动脉瘤时,肾上/腹腔动脉上钳夹(25/200)的使用频率高于肾下钳夹(9/516)(12.5%对1.74%)。两组的手术时间相似,但肾上/腹腔动脉上组的输血需求量和住院时间略长。围手术期总体死亡率为3.1%,但肾上/腹腔动脉上组高于肾下组(7.5%对1.4%)。接受肾上/腹腔动脉上钳夹的患者中有26例(13%)出现术后并发症。另有9例患者需要再次进行腹部探查。我们得出结论,尽管存在相关合并症,但在肾下腹主动脉瘤修复过程中进行择期肾上/腹腔动脉上钳夹是安全的,便于修复,且不会显著增加死亡率。